UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Two Randomized Trials of Linaclotide for Chronic Constipation

The New England journal of medicine, 2011-08, Vol.365 (6), p.527-536

2011

Volltextzugriff (PDF)

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial

PloS one, 2015-07, Vol.10 (7), p.e0134349-e0134349

2015

Volltextzugriff (PDF)

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

The American journal of gastroenterology, 2012-11, Vol.107 (11), p.1702-1712

2012

Volltextzugriff (PDF)

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

The American journal of gastroenterology, 2012-11, Vol.107 (11), p.1714-1724

2012

Volltextzugriff (PDF)

Response to Miner et al

The American journal of gastroenterology, 2017-11, Vol.112 (11), p.1750-1751

2017

Volltextzugriff (PDF)

Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation

Clinical gastroenterology and hepatology, 2014-04, Vol.12 (4), p.616-623

2014

Volltextzugriff (PDF)

Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention

Oral oncology, 2005-07, Vol.41 (6), p.562-567

2005

Volltextzugriff (PDF)

A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation

Current medical research and opinion, 2013-02, Vol.29 (2), p.149-160

2013

Volltextzugriff (PDF)

Tu1070 The Effect of Linaclotide on IBS-QOL Sexual Subscale Scores in Patients With Irritable Bowel Syndrome With Constipation: Results From a Post Hoc Analysis of 2 Phase 3 Trials of Linaclotide

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-752-S-753

2013

Volltextzugriff (PDF)

Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and Apoptosis

Experimental cell research, 1996-01, Vol.222 (1), p.179-188

1996

Volltextzugriff (PDF)

Sa2008 Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-353-S-353

2014

Volltextzugriff (PDF)

Efficacy and Safety of Once Daily Linaclotide in Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Followed by a 4-Week Randomized Withdrawal Period

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-138-S-138

2011

Volltextzugriff (PDF)

Tu1380 Assessing the Percent of Days Linaclotide Improved Abdominal Symptoms and Stool Frequency in Patients With IBS-C: A Pooled Analysis of Two Phase 3 Trials

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-816-S-817

2012

Volltextzugriff (PDF)

Tu1401 Factors Contributing to Treatment Satisfaction in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Treated With Linaclotide vs Placebo

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-822-S-823

2012

Volltextzugriff (PDF)

Su2033 Determining the Minimum Duration for Initial Treatment With Linaclotide in IBS-C Patients: Results From Pooled Phase 3 Trials

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-537-S-538

2013

Volltextzugriff (PDF)

Mo2054 Assessing Abdominal and Bowel Symptoms Using Adequate Relief Based Thresholds: Results From 2 Phase 3 Trials of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-728-S-729

2013

Volltextzugriff (PDF)

Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells

Biochemical pharmacology, 1998, Vol.55 (1), p.53-64

1998

Volltextzugriff (PDF)

Mo1858 Characterization and Association of Abdominal Pain With Anxiety or Depression in Patients With Irritable Bowel Syndrome With Constipation

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-701-S-702

2012

Volltextzugriff (PDF)

Sa1098 Mediation Analysis Supports a Direct Effect of Linaclotide on Relief of Abdominal Pain Independent of Constipation Improvement

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-215-S-216

2012

Volltextzugriff (PDF)

848 Efficacy of Linaclotide in Improving Abdominal Symptoms Rated as Most Severe by Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-144-S-144

2012

Volltextzugriff (PDF)

Tu1423 Effects of Linaclotide on Straining Associated With Bowel Movements in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A Post Hoc Analysis of Pooled Data From Two Phase 3 Trials

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-828-S-829

2012

Volltextzugriff (PDF)

Tu1069 Do Baseline Factors Contribute to Treatment Satisfaction in Patients With Chronic Constipation Treated With Linaclotide vs Placebo?

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-737-S-738

2012

Volltextzugriff (PDF)

Mo1856 Linaclotide Significantly Improved Abdominal Pain Compared With Placebo in Patients With Irritable Bowel Syndrome Regardless of Baseline Pain Severity in Two Phase 3 Trials

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-701-S-701

2012

Volltextzugriff (PDF)

Cyclooxygenase inhibitors: drugs for cancer prevention

Current opinion in pharmacology, 2003-08, Vol.3 (4), p.352-361

2003

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(79)
Berichte
(1)

Sprache

Englisch
(80)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Humans
(40)
Life Sciences & Biomedicine
(40)
Gastroenterology And Hepatology
(23)
Biological And Medical Sciences
(15)
Female
(15)
Medical Sciences
(15)
Cell Division - Drug Effects
(14)
Male
(13)
Oncology
(13)
Apoptosis
(11)
Apoptosis - Drug Effects
(11)
Adult
(9)
Aged
(9)
Anti-Inflammatory Agents, Non-Steroidal - Pharmacology
(9)
Colonic Neoplasms - Pathology
(9)
Middle Aged
(9)
Treatment Outcome
(9)
Animals
(8)
Gastroenterology & Hepatology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Two Randomized Trials of Linaclotide for Chronic Constipation

Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis

Response to Miner et al

Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation

Selection of topically applied non-steroidal anti-inflammatory drugs for oral cancer chemoprevention

A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation

Tu1070 The Effect of Linaclotide on IBS-QOL Sexual Subscale Scores in Patients With Irritable Bowel Syndrome With Constipation: Results From a Post Hoc Analysis of 2 Phase 3 Trials of Linaclotide

Nonsteroidal Antiinflammatory Drugs Inhibit the Proliferation of Colon Adenocarcinoma Cells: Effects on Cell Cycle and Apoptosis

Sa2008 Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results

Efficacy and Safety of Once Daily Linaclotide in Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Followed by a 4-Week Randomized Withdrawal Period

Tu1380 Assessing the Percent of Days Linaclotide Improved Abdominal Symptoms and Stool Frequency in Patients With IBS-C: A Pooled Analysis of Two Phase 3 Trials

Tu1401 Factors Contributing to Treatment Satisfaction in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Treated With Linaclotide vs Placebo

Su2033 Determining the Minimum Duration for Initial Treatment With Linaclotide in IBS-C Patients: Results From Pooled Phase 3 Trials

Mo2054 Assessing Abdominal and Bowel Symptoms Using Adequate Relief Based Thresholds: Results From 2 Phase 3 Trials of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells

Mo1858 Characterization and Association of Abdominal Pain With Anxiety or Depression in Patients With Irritable Bowel Syndrome With Constipation

Sa1098 Mediation Analysis Supports a Direct Effect of Linaclotide on Relief of Abdominal Pain Independent of Constipation Improvement

848 Efficacy of Linaclotide in Improving Abdominal Symptoms Rated as Most Severe by Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Tu1423 Effects of Linaclotide on Straining Associated With Bowel Movements in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A Post Hoc Analysis of Pooled Data From Two Phase 3 Trials

Tu1069 Do Baseline Factors Contribute to Treatment Satisfaction in Patients With Chronic Constipation Treated With Linaclotide vs Placebo?

Mo1856 Linaclotide Significantly Improved Abdominal Pain Compared With Placebo in Patients With Irritable Bowel Syndrome Regardless of Baseline Pain Severity in Two Phase 3 Trials

Cyclooxygenase inhibitors: drugs for cancer prevention

Suchergebnisse filtern